Items | GenS | Urol | NeuroS | Gyn | HepaB | Ortho | GiS | OncoS | Others | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
Prescriptions (n) | 369 | 645 | 431 | 511 | 327 | 185 | 418 | 26 | 77 | 2989 | |
Antibiotics use rate (%) | 31.59 | 50.98 | 21.62 | 23.95 | 45.34 | 22.14 | 36.17 | 15.94 | 18.68 | 31.91 | |
Surgical type (%) | Clean | 9.52 | 23.37 | 64.29 | 22.92 | 16.09 | 69.48 | 14.22 | Â | 40.91 | 31.29 |
Contaminated | 29.25 | 37.38 | 8.65 | 68.06 | 48.85 | 10.39 | 62.84 | 77.78 | 25.00 | 39.57 | |
Infected | 7.48 | 0.62 | 1.13 | 1.74 | 8.62 | 9.74 | 1.83 | Â | 4.55 | 3.50 | |
Unknown | 53.74 | 38.63 | 25.94 | 7.29 | 26.44 | 10.39 | 21.10 | 22.22 | 29.55 | 25.64 | |
Antibiotics use purpose (%) | Therapeutics | 52.57 | 55.19 | 43.62 | 25.05 | 43.73 | 11.35 | 35.41 | 26.92 | 57.14 | 41.12 |
Prophylaxis | 26.02 | 32.25 | 51.04 | 74.17 | 51.07 | 81.62 | 60.77 | 73.08 | 23.38 | 50.59 | |
Unknown | 21.41 | 12.56 | 5.34 | 0.78 | 5.20 | 7.03 | 3.83 | Â | 19.48 | 8.30 | |
Therapeutics (%) | Empiric | 85.35 | 87.19 | 61.14 | 89.39 | 93.75 | 50.00 | 87.81 | 85.70 | 89.83 | 83.34 |
Targeted | 2.57 | 7.78 | 33.65 | 6.08 | 3.13 | 38.25 | 6.092 | 14.30 | 3.39 | 10.22 | |
Unknown | 12.08 | 5.03 | 5.21 | 4.53 | 3.13 | 11.75 | 6.09 | Â | 6.77 | 6.44 | |
Surgical prophylaxis (%) | 57.14 | 59.50 | 76.69 | 95.14 | 76.44 | 95.45 | 83.49 | 94.44 | 38.64 | 76.63 | |
AUI (DDDs/100 patient.day) | 43.82 | 73.67 | 31.42 | 43.23 | 67.68 | 27.70 | 62.79 | 40.19 | 23.74 | 45.81 | |
Guidelines(%) | Complied | 73.71 | 78.14 | 83.29 | 82.78 | 81.96 | 90.81 | 77.03 | 100 | 76.62 | 80.33 |
Non-complied | 9.49 | 15.50 | 10.90 | 11.15 | 11.62 | 4.32 | 12.44 | Â | 3.90 | 11.38 | |
Unavailable | 6.50 | 1.86 | 0.93 | Â | 0.92 | Â | 6.22 | Â | 14.29 | 2.68 | |
No guideline | 1.36 | 0.62 | 0.93 | Â | 0.92 | 1.08 | Â | Â | 1.30 | 0.64 | |
Unknown | 8.94 | 3.88 | 3.94 | 6.07 | 4.59 | 3.78 | 4.31 | Â | 3.90 | 4.98 | |
Therapy referring to biomarkers (%) | 28.46 | 40.00 | 20.42 | 14.48 | 21.10 | 2.16 | 19.38 | 23.08 | 46.75 | 24.12 | |
Prescription reason recorded (%) | 29.81 | 17.36 | 6.73 | 7.83 | 14.98 | 2.16 | 10.29 | 23.08 | 40.26 | 14.19 | |
Therapeutic duration up to PPS (d) |  ≤ 3 | 32.96 | 33.15 | 23.69 | 52.26 | 38.12 | 29.43 | 29.88 | 71.43 | 38.98 | 36.89 |
4–7 | 33.33 | 42.95 | 21.32 | 34.84 | 24.99 | 32.37 | 35.34 | 28.57 | 38.98 | 32.23 | |
8–14 | 13.19 | 17.99 | 22.75 | 10.61 | 27.51 | 11.75 | 21.95 |  | 13.56 | 17.40 | |
 ≥ 15 | 18.31 | 2.68 | 27.96 | 1.51 | 6.25 | 17.63 | 9.15 |  | 5.09 | 10.50 | |
Unknown | 2.20 | 3.22 | 4.27 | 0.77 | 3.13 | 8.81 | 3.67 | Â | 3.39 | 2.97 | |
Administrative route (%) | Intravenous | 96.00 | 94.20 | 93.54 | 83.71 | 97.48 | 91.27 | 97.14 | 97.37 | 95.38 | 93.66 |
Oral | 1.23 | 3.48 | 1.90 | 16.01 | 0.31 | 5.56 | 1.04 | Â | 1.54 | 4.04 | |
Others | Â | 0.34 | Â | Â | Â | 0.79 | Â | 2.63 | Â | 0.16 | |
Unknown | 2.77 | 1.99 | 4.56 | 0.28 | 2.20 | 2.38 | 1.82 | Â | 3.08 | 2.14 | |
Combinatory use (%) | Single | 63.84 | 74.95 | 76.56 | 40.21 | 64.65 | 58.62 | 41.79 | 36.36 | 78.43 | 63.05 |
2 drugs | 29.91 | 21.63 | 21.53 | 46.91 | 27.91 | 39.08 | 40.30 | 59.09 | 17.65 | 30.00 | |
 ≥ 3 drugs | 6.25 | 3.43 | 1.92 | 12.88 | 7.45 | 2.30 | 17.92 | 4.55 | 3.92 | 6.94 | |
Stop or review recorded (%) | 58.27 | 39.84 | 19.72 | 16.83 | 25.08 | 5.95 | 16.99 | 23.08 | 61.04 | 44.94 |